Please provide your email address to receive an email when new articles are posted on . IVUS may improve care of patients undergoing peripheral revascularization. More data are needed to document ...
The FDA approved the LimFlow system designed to stave off amputation for people with chronic limb-threatening ischemia (CLTI) and no treatment alternatives, device maker LimFlow SA announced Tuesday.
New studies underscore the importance of inclusive approaches in peripheral artery disease treatment
New clinical results highlight the need for inclusive approaches and comprehensive examinations of treatment options for peripheral artery disease (PAD), including endovascular therapy and ...
Please provide your email address to receive an email when new articles are posted on . Among patients with peripheral artery disease who had an endovascular procedure, treatment with a drug-coated ...
Treatment with rivaroxaban plus aspirin significantly reduced the risk of major adverse limb and cardiovascular events in the VOYAGER PAD study. A supplemental New Drug Application (sNDA) for ...
Compared with white patients, Black patients with PAD who undergo peripheral revascularization have much more advanced disease at the time of their procedures and are less likely to receive necessary ...
Measured one way, success for peripheral vascular intervention (PVI) in the femoropopliteal arteries for patients with intermittent claudication has improved, as the need for repeat PVI appears to be ...
Rivaroxaban, in addition to low-dose aspirin, significantly reduced the occurrence of total severe events of the heart, limb or brain and issues related to other vascular complications in patients ...
Assessing Long-Term Outcomes of Tirzepatide and Semaglutide in Heart Failure With Preserved Ejection Fraction: A Retrospective Cohort Analysis From TrinetX Database Receive the the latest news, ...
The treatment of patients with peripheral arterial disease has evolved tremendously since the early 1960s, when Charles Dotter first successfully revascularized a superficial femoral artery occlusion ...
Dr. Faris Galambo is a board-certified interventional and diagnostic radiologist at the University of Utah, where he serves as Associate Program Director of the Integrated IR/DR Residency. His ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback